243 related articles for article (PubMed ID: 8304361)
1. Osteoporosis and bone morbidity in cardiac transplant recipients.
Lee AH; Mull RL; Keenan GF; Callegari PE; Dalinka MK; Eisen HJ; Mancini DM; DiSesa VJ; Attie MF
Am J Med; 1994 Jan; 96(1):35-41. PubMed ID: 8304361
[TBL] [Abstract][Full Text] [Related]
2. Bone mass, vitamin D deficiency, and hyperparathyroidism in congestive heart failure.
Shane E; Mancini D; Aaronson K; Silverberg SJ; Seibel MJ; Addesso V; McMahon DJ
Am J Med; 1997 Sep; 103(3):197-207. PubMed ID: 9316552
[TBL] [Abstract][Full Text] [Related]
3. Determinants of bone mineral density in stable kidney transplant recipients.
Gupta AK; Huang M; Prasad GV
J Nephrol; 2012; 25(3):373-83. PubMed ID: 21928224
[TBL] [Abstract][Full Text] [Related]
4. Osteoporosis in lung transplantation candidates with end-stage pulmonary disease.
Shane E; Silverberg SJ; Donovan D; Papadopoulos A; Staron RB; Addesso V; Jorgesen B; McGregor C; Schulman L
Am J Med; 1996 Sep; 101(3):262-9. PubMed ID: 8873487
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of osteoporosis, osteopenia, and vertebral fractures in long-term renal transplant recipients.
Marcén R; Caballero C; Uriol O; Fernández A; Villafruela JJ; Pascual J; Martins J; Rodriguez N; Burgos FJ; Ortuño J
Transplant Proc; 2007 Sep; 39(7):2256-8. PubMed ID: 17889156
[TBL] [Abstract][Full Text] [Related]
6. Prevention of bone loss after heart transplantation with antiresorptive therapy: a pilot study.
Shane E; Rodino MA; McMahon DJ; Addesso V; Staron RB; Seibel MJ; Mancini D; Michler RE; Lo SH
J Heart Lung Transplant; 1998 Nov; 17(11):1089-96. PubMed ID: 9855448
[TBL] [Abstract][Full Text] [Related]
7. [Bone density and laboratory parameters of bone metabolism in patients with terminal heart disease].
Christ E; Linka A; Junga G; Odermatt M; Steinert H; Kiowski W; Schmid C
Schweiz Med Wochenschr; 1996 Sep; 126(37):1553-9. PubMed ID: 8927958
[TBL] [Abstract][Full Text] [Related]
8. Bone Disease and Serum Fibroblast Growth Factor-23 Levels in Renal Transplant Recipients.
Coskun Y; Paydas S; Balal M; Soyupak S; Kara E
Transplant Proc; 2016; 48(6):2040-5. PubMed ID: 27569941
[TBL] [Abstract][Full Text] [Related]
9. Effects of calcium supplementation on bone loss and fractures in congestive heart failure.
Frost RJ; Sonne C; Wehr U; Stempfle HU
Eur J Endocrinol; 2007 Mar; 156(3):309-14. PubMed ID: 17322490
[TBL] [Abstract][Full Text] [Related]
10. Long-term bone loss in kidney transplant recipients: a cross-sectional and longitudinal study.
Pichette V; Bonnardeaux A; Prudhomme L; Gagné M; Cardinal J; Ouimet D
Am J Kidney Dis; 1996 Jul; 28(1):105-14. PubMed ID: 8712204
[TBL] [Abstract][Full Text] [Related]
11. Reduced bone mineral density in male renal transplant recipients: evidence for persisting hyperparathyroidism.
Roe SD; Porter CJ; Godber IM; Hosking DJ; Cassidy MJ
Osteoporos Int; 2005 Feb; 16(2):142-8. PubMed ID: 15258722
[TBL] [Abstract][Full Text] [Related]
12. Cyclosporine induces high bone turnover and may contribute to bone loss after heart transplantation.
Thiébaud D; Krieg MA; Gillard-Berguer D; Jacquet AF; Goy JJ; Burckhardt P
Eur J Clin Invest; 1996 Jul; 26(7):549-55. PubMed ID: 8864416
[TBL] [Abstract][Full Text] [Related]
13. Ibandronate in stable renal transplant recipients with low bone mineral density on long-term follow-up.
Tillmann FP; Schmitz M; Jäger M; Krauspe R; Rump LC
Int Urol Nephrol; 2016 Feb; 48(2):279-86. PubMed ID: 26498632
[TBL] [Abstract][Full Text] [Related]
14. Changes in bone mineral density after kidney transplantation: 2-year assessment of a French cohort.
Segaud N; Legroux I; Hazzan M; Noel C; Cortet B
Osteoporos Int; 2018 May; 29(5):1165-1175. PubMed ID: 29500526
[TBL] [Abstract][Full Text] [Related]
15. Status of bone mineral density in patients selected for cardiac transplantation.
Iqbal N; Ducharme J; Desai S; Chambers S; Terembula K; Chan GW; Shults J; Leonard MB; Kumanyika S
Endocr Pract; 2008 Sep; 14(6):704-12. PubMed ID: 18996789
[TBL] [Abstract][Full Text] [Related]
16. Cyclosporine A and prednisone-associated osteoporosis in heart transplant recipients.
Rich GM; Mudge GH; Laffel GL; LeBoff MS
J Heart Lung Transplant; 1992; 11(5):950-8. PubMed ID: 1420244
[TBL] [Abstract][Full Text] [Related]
17. Inverse association of serum long-acting natriuretic peptide and bone mineral density in renal transplant recipients.
Hsu BG; Ho GJ; Lee CJ; Yang YC; Chen YC; Shih MH; Lee MC
Clin Transplant; 2012; 26(2):E105-10. PubMed ID: 22211802
[TBL] [Abstract][Full Text] [Related]
18. Prevention of osteoporosis in heart transplant recipients: a comparison of calcitriol with calcitonin and pamidronate.
Bianda T; Linka A; Junga G; Brunner H; Steinert H; Kiowski W; Schmid C
Calcif Tissue Int; 2000 Aug; 67(2):116-21. PubMed ID: 10920215
[TBL] [Abstract][Full Text] [Related]
19. Effects of alendronate on bone mineral density and bone metabolic markers in patients with liver transplantation.
Atamaz F; Hepguler S; Akyildiz M; Karasu Z; Kilic M
Osteoporos Int; 2006; 17(6):942-9. PubMed ID: 16550299
[TBL] [Abstract][Full Text] [Related]
20. Loss of regional bone mineral density in the first 12 months following renal transplantation.
Almond MK; Kwan JT; Evans K; Cunningham J
Nephron; 1994; 66(1):52-7. PubMed ID: 8107953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
